KLRD1, FOSL2 and LILRB3 as potential biomarkers for plaques progression in acute myocardial infarction and stable coronary artery disease

BMC Cardiovasc Disord. 2021 Jul 16;21(1):344. doi: 10.1186/s12872-021-01997-5.

Abstract

Background: Myocardial infarction (MI) contributes to high mortality and morbidity and can also accelerate atherosclerosis, thus inducing recurrent event due to status changing of coronary artery walls or plaques. The research aimed to investigate the differentially expressed genes (DEGs), which may be potential therapeutic targets for plaques progression in stable coronary artery disease (CAD) and ST-elevated MI (STEMI).

Methods: Two human datasets (GSE56885 and GSE59867) were analyzed by GEO2R and enrichment analysis was applied through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. To explore the seed genes, the protein-protein interaction (PPI) network was constructed and seed genes, as well as top30 ranking neighbours were screened out. To validate these findings, one human dataset GSE120521 was analyzed. Linear regression analysis and ROC curve were also performed to determine which seed genes above mentioned could be independent factors for plaques progression. Mice MI model and ELISA of seed genes were applied and ROC curve was also performed for in vivo validation.

Results: 169 DEGs and 573 DEGs were screened out in GSE56885 and GSE59867, respectively. Utilizing GO and KEGG analysis, these DEGs mainly enriched in immune system response and cytokines interaction. PPI network analysis was carried out and 19 seed genes were screened out. To validate these findings, GSE120521 was analyzed and three genes were demonstrated to be targets for plaques progression and stable CAD progression, including KLRD1, FOSL2 and LILRB3. KLRD1 and LILRB3 were demonstrated to be high-expressed at 1d after MI compared to SHAM group and FOSL2 expression was low-expressed at 1d and 1w. To investigate the diagnostic abilities of seed genes, ROC analysis was applied and the AUCs of KLRD1, FOSL2 and LILRB3, were 0.771, 0.938 and 0.972, respectively.

Conclusion: This study provided the screened seed genes, KLRD1, FOSL2 and LILRB3, as credible molecular biomarkers for plaques status changing in CAD progression and MI recurrence. Other seed genes, such as FOS, SOCS3 and MCL1, may also be potential targets for treatment due to their special clinical value in cardiovascular diseases.

Keywords: GEO; PPI; STEMI; Stable CAD; WebGestalt.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / genetics*
  • Antigens, CD / metabolism
  • Case-Control Studies
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / genetics*
  • Coronary Artery Disease / metabolism
  • Databases, Genetic
  • Disease Models, Animal
  • Disease Progression
  • Fos-Related Antigen-2 / genetics*
  • Fos-Related Antigen-2 / metabolism
  • Gene Regulatory Networks
  • Genetic Markers
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NK Cell Lectin-Like Receptor Subfamily D / genetics*
  • NK Cell Lectin-Like Receptor Subfamily D / metabolism
  • Plaque, Atherosclerotic*
  • Protein Interaction Maps
  • Receptors, Immunologic / genetics*
  • Receptors, Immunologic / metabolism
  • Recurrence
  • ST Elevation Myocardial Infarction / diagnostic imaging
  • ST Elevation Myocardial Infarction / genetics*
  • ST Elevation Myocardial Infarction / metabolism
  • Signal Transduction

Substances

  • Antigens, CD
  • FOSL2 protein, human
  • Fos-Related Antigen-2
  • Fosl2 protein, mouse
  • Genetic Markers
  • KLRD1 protein, human
  • Klrd1 protein, mouse
  • LILRB3 protein, human
  • NK Cell Lectin-Like Receptor Subfamily D
  • Pirb protein, mouse
  • Receptors, Immunologic